Medivolve Inc. (MEDVF)
USD 0.01
(133.33%)
USD 0.01
(133.33%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -3.58 Million CAD | 84.29% |
| 2022 | -22.79 Million CAD | -2035.45% |
| 2021 | 1.17 Million CAD | 105.31% |
| 2020 | -22.19 Million CAD | -831.75% |
| 2019 | -2.38 Million CAD | -85.08% |
| 2018 | -1.28 Million CAD | 68.3% |
| 2017 | -4.06 Million CAD | -367.86% |
| 2016 | -867.81 Thousand CAD | 12.25% |
| 2015 | -989 Thousand CAD | 49.08% |
| 2014 | -1.94 Million CAD | -16.29% |
| 2013 | -1.67 Million CAD | 2.38% |
| 2012 | -1.71 Million CAD | 17.78% |
| 2011 | -2.08 Million CAD | -0.08% |
| 2010 | -2.07 Million CAD | -14.74% |
| 2009 | -1.81 Million CAD | -42.23% |
| 2008 | -1.27 Million CAD | -818.51% |
| 2007 | -138.69 Thousand CAD | -3.14% |
| 2006 | -134.47 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -601.83 Thousand CAD | -20.06% |
| 2023 Q3 | -1.33 Million CAD | 43.29% |
| 2023 FY | -3.58 Million CAD | 84.29% |
| 2023 Q4 | -501.25 Thousand CAD | 62.46% |
| 2023 Q1 | -2.35 Million CAD | 52.6% |
| 2023 Q2 | -2.35 Million CAD | 0.07% |
| 2022 Q4 | -4.97 Million CAD | 28.69% |
| 2022 Q3 | -6.97 Million CAD | 27.86% |
| 2022 Q2 | -9.66 Million CAD | -715.99% |
| 2022 FY | -22.79 Million CAD | -2035.45% |
| 2022 Q1 | -1.18 Million CAD | -106.26% |
| 2021 FY | 1.17 Million CAD | 105.31% |
| 2021 Q1 | -9.14 Million CAD | 21.19% |
| 2021 Q2 | -4.21 Million CAD | 53.95% |
| 2021 Q3 | 6.8 Million CAD | 261.57% |
| 2021 Q4 | 18.91 Million CAD | 177.84% |
| 2020 Q4 | -11.6 Million CAD | -402.41% |
| 2020 FY | -22.19 Million CAD | -831.75% |
| 2020 Q1 | -1 Million CAD | -0.29% |
| 2020 Q2 | -6.95 Million CAD | -595.49% |
| 2020 Q3 | -2.31 Million CAD | 66.8% |
| 2019 Q3 | -306.95 Thousand CAD | 62.4% |
| 2019 FY | -2.38 Million CAD | -85.08% |
| 2019 Q1 | -260.72 Thousand CAD | 49.83% |
| 2019 Q2 | -816.43 Thousand CAD | -213.13% |
| 2019 Q4 | -997.83 Thousand CAD | -225.07% |
| 2018 Q4 | -519.69 Thousand CAD | -73.25% |
| 2018 Q3 | -299.96 Thousand CAD | -164.13% |
| 2018 Q2 | -113.56 Thousand CAD | 65.29% |
| 2018 FY | -1.28 Million CAD | 68.3% |
| 2018 Q1 | -327.22 Thousand CAD | 89.36% |
| 2017 Q4 | -3.07 Million CAD | -795.61% |
| 2017 FY | -4.06 Million CAD | -367.86% |
| 2017 Q3 | -343.29 Thousand CAD | -19.0% |
| 2017 Q2 | -288.48 Thousand CAD | 18.47% |
| 2017 Q1 | -353.82 Thousand CAD | 45.85% |
| 2016 Q3 | 74.97 Thousand CAD | 150.59% |
| 2016 Q2 | -148.2 Thousand CAD | -4.97% |
| 2016 Q1 | -141.18 Thousand CAD | 37.48% |
| 2016 FY | -867.81 Thousand CAD | 12.25% |
| 2016 Q4 | -653.39 Thousand CAD | -971.53% |
| 2015 FY | -989 Thousand CAD | 49.08% |
| 2015 Q4 | -225.83 Thousand CAD | 9.42% |
| 2015 Q3 | -249.3 Thousand CAD | -6.11% |
| 2015 Q2 | -234.95 Thousand CAD | 15.76% |
| 2015 Q1 | -278.91 Thousand CAD | 51.96% |
| 2014 Q2 | -680.48 Thousand CAD | -85.9% |
| 2014 Q1 | -366.04 Thousand CAD | 10.26% |
| 2014 Q3 | -315.15 Thousand CAD | 53.69% |
| 2014 FY | -1.94 Million CAD | -16.29% |
| 2014 Q4 | -580.63 Thousand CAD | -84.24% |
| 2013 Q3 | -448.66 Thousand CAD | -7.82% |
| 2013 Q1 | -397.62 Thousand CAD | 13.54% |
| 2013 Q2 | -416.1 Thousand CAD | -4.65% |
| 2013 Q4 | -407.88 Thousand CAD | 9.09% |
| 2013 FY | -1.67 Million CAD | 2.38% |
| 2012 FY | -1.71 Million CAD | 17.78% |
| 2012 Q4 | -459.89 Thousand CAD | -12.85% |
| 2012 Q3 | -407.52 Thousand CAD | -11.24% |
| 2012 Q2 | -366.34 Thousand CAD | 23.23% |
| 2012 Q1 | -477.2 Thousand CAD | -7.58% |
| 2011 Q3 | -248.51 Thousand CAD | 75.49% |
| 2011 Q1 | -375.03 Thousand CAD | 14.43% |
| 2011 FY | -2.08 Million CAD | -0.08% |
| 2011 Q2 | -1.01 Million CAD | -170.3% |
| 2011 Q4 | -443.58 Thousand CAD | -78.5% |
| 2010 Q4 | -438.29 Thousand CAD | -8.8% |
| 2010 Q3 | -402.85 Thousand CAD | 34.81% |
| 2010 Q2 | -617.97 Thousand CAD | 0.33% |
| 2010 FY | -2.07 Million CAD | -14.74% |
| 2010 Q1 | -620.02 Thousand CAD | -92.8% |
| 2009 Q2 | -292.2 Thousand CAD | 10.64% |
| 2009 FY | -1.81 Million CAD | -42.23% |
| 2009 Q3 | -871.2 Thousand CAD | -198.15% |
| 2009 Q1 | -327 Thousand CAD | -125.16% |
| 2009 Q4 | -321.59 Thousand CAD | 63.09% |
| 2008 Q1 | -53.48 Thousand CAD | 43.07% |
| 2008 Q4 | 1.29 Million CAD | 158.39% |
| 2008 Q3 | -2.22 Million CAD | -659.33% |
| 2008 FY | -1.27 Million CAD | -818.51% |
| 2008 Q2 | -293.08 Thousand CAD | -448.03% |
| 2007 Q1 | -5377.00 CAD | 24.95% |
| 2007 Q3 | -39.17 Thousand CAD | -18205.61% |
| 2007 Q4 | -93.93 Thousand CAD | -139.79% |
| 2007 Q2 | -214.00 CAD | 96.02% |
| 2007 FY | -138.69 Thousand CAD | -3.14% |
| 2006 FY | -134.47 Thousand CAD | 0.0% |
| 2006 Q2 | -54.84 Thousand CAD | -29.41% |
| 2006 Q4 | -7165.00 CAD | 76.18% |
| 2006 Q1 | -42.38 Thousand CAD | 0.0% |
| 2006 Q3 | -30.08 Thousand CAD | 45.16% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.24 Million USD | -188.247% |
| Arrayit Corporation | -3.62 Million USD | 1.173% |
| Atlantic International Corp. | -5.73 Million USD | 37.549% |
| Biocept, Inc. | -31.98 Million USD | 88.806% |
| Bioqual, Inc. | -19.63 Thousand USD | -18130.125% |
| CardioGenics Holdings Inc | -772.14 Thousand USD | -363.649% |
| DermTech, Inc. | -103.73 Million USD | 96.549% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.48 Billion USD | 100.144% |
| HTG Molecular Diagnostics, Inc. | -20.82 Million USD | 82.813% |
| iMD Companies, Inc. | -175.44 Thousand USD | -1940.532% |
| IDenta Corp. | -1499.00 USD | -238728.019% |
| Interpace Biosciences, Inc. | 2.8 Million USD | 227.676% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 9353.12% |
| InVitro International | -25.33 Thousand USD | -14028.545% |
| Lumos Diagnostics Holdings Limited | -7.12 Million USD | 49.733% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -6060.573% |
| Medical Imaging Corp. | -819.48 Thousand USD | -336.866% |
| NovelStem International Corp. | -3.52 Million USD | -1.538% |
| Optigenex Inc. | 1.39 Million USD | 357.402% |
| PharmChem, Inc. | 973.14 Thousand USD | 467.882% |
| Proteome Sciences plc | -1.62 Million USD | -120.853% |
| Response Genetics, Inc | -21.37 Million USD | 83.253% |
| Rennova Health, Inc. | -1.4 Million USD | -153.987% |
| RushNet, Inc. | -684.7 Thousand USD | -422.858% |
| ScreenPro Security Inc. | -2.59 Million USD | -38.096% |
| Stella Diagnostics Inc. | -11.42 Million USD | 68.67% |
| StageZero Life Sciences Ltd. | -7.74 Million USD | 53.787% |
| Todos Medical Ltd. | -9.74 Million USD | 63.274% |